TPM3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.46930287118153E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.97709999985685E-08 |
Normal-vs-Stage2 |
1.479470E-03 |
Normal-vs-Stage3 |
2.13770000001556E-06 |
Normal-vs-Stage4 |
1.067730E-02 |
Stage1-vs-Stage2 |
9.487600E-01 |
Stage1-vs-Stage3 |
3.501700E-02 |
Stage1-vs-Stage4 |
2.781800E-01 |
Stage2-vs-Stage3 |
1.269240E-01 |
Stage2-vs-Stage4 |
3.374400E-01 |
Stage3-vs-Stage4 |
8.087600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.49290033060845E-10 |
Normal-vs-AfricanAmerican |
6.51480003277527E-09 |
Normal-vs-Asian |
1.421640E-01 |
Caucasian-vs-AfricanAmerican |
8.944200E-01 |
Caucasian-vs-Asian |
9.953000E-01 |
AfricanAmerican-vs-Asian |
9.578800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.19040024901562E-10 |
Normal-vs-Female |
8.4670004341092E-10 |
Male-vs-Female |
1.484420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.23470000001902E-06 |
Normal-vs-Extreme_Weight |
4.01080000322906E-08 |
Normal-vs-Obese |
8.91100004896117E-09 |
Normal-vs-Extreme_Obese |
2.883400E-01 |
Normal_Weight-vs-Extreme_Weight |
6.871400E-01 |
Normal_Weight-vs-Obese |
7.142200E-01 |
Normal_Weight-vs-Extreme_Obese |
1.233160E-01 |
Extreme_Weight-vs-Obese |
3.757400E-01 |
Extreme_Weight-vs-Extreme_Obese |
1.415170E-01 |
Obese-vs-Extreme_Obese |
7.008000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.003510E-04 |
Normal-vs-Age(41-60Yrs) |
5.80919756743015E-11 |
Normal-vs-Age(61-80Yrs) |
7.20049997404715E-09 |
Normal-vs-Age(81-100Yrs) |
1.091600E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.548170E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.600000E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.149800E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.957040E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.297380E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.524600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.6960988169501E-11 |
Normal-VS-Type2 PRCC |
4.02320000000289E-05 |
Normal-VS-KIRP CIMP |
2.56080001648229E-09 |
Normal-VS-Unclassified PRCC |
2.56639999995922E-06 |
Type1 PRCC-VS-Type2 PRCC |
8.339900E-02 |
Type1 PRCC-VS-KIRP CIMP |
2.580300E-02 |
Type1 PRCC-VS-Unclassified PRCC |
9.888000E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.465720E-02 |
Type2 PRCC-VS-Unclassified PRCC |
2.366600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
6.043700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.27420000000245E-05 |
Normal-vs-N1 |
1.00719999995835E-06 |
Normal-vs-N2 |
2.193600E-01 |
N0-vs-N1 |
3.300800E-03 |
N0-vs-N2 |
6.840000E-01 |
N1-vs-N2 |
3.668800E-01 |
|
|